233 related articles for article (PubMed ID: 19034353)
21. The cutaneous innate immune response in patients with atopic dermatitis.
Kuo IH; Yoshida T; De Benedetto A; Beck LA
J Allergy Clin Immunol; 2013 Feb; 131(2):266-78. PubMed ID: 23374259
[TBL] [Abstract][Full Text] [Related]
22. Precision medicine in patients with allergic diseases: Airway diseases and atopic dermatitis-PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology.
Muraro A; Lemanske RF; Hellings PW; Akdis CA; Bieber T; Casale TB; Jutel M; Ong PY; Poulsen LK; Schmid-Grendelmeier P; Simon HU; Seys SF; Agache I
J Allergy Clin Immunol; 2016 May; 137(5):1347-58. PubMed ID: 27155030
[TBL] [Abstract][Full Text] [Related]
23. Cellular and molecular mechanisms in atopic dermatitis.
Oyoshi MK; He R; Kumar L; Yoon J; Geha RS
Adv Immunol; 2009; 102():135-226. PubMed ID: 19477321
[TBL] [Abstract][Full Text] [Related]
24. Bee Venom Phospholipase A2 Ameliorates House Dust Mite Extract Induced Atopic Dermatitis Like Skin Lesions in Mice.
Jung KH; Baek H; Kang M; Kim N; Lee SY; Bae H
Toxins (Basel); 2017 Feb; 9(2):. PubMed ID: 28218721
[TBL] [Abstract][Full Text] [Related]
25. From atopic dermatitis to asthma: the atopic march.
Spergel JM
Ann Allergy Asthma Immunol; 2010 Aug; 105(2):99-106; quiz 107-9, 117. PubMed ID: 20674819
[TBL] [Abstract][Full Text] [Related]
26. Sensitive skin is highly frequent in extrinsic atopic dermatitis and correlates with disease severity markers but not necessarily with skin barrier impairment.
Yatagai T; Shimauchi T; Yamaguchi H; Sakabe JI; Aoshima M; Ikeya S; Tatsuno K; Fujiyama T; Ito T; Ojima T; Tokura Y
J Dermatol Sci; 2018 Jan; 89(1):33-39. PubMed ID: 29122406
[TBL] [Abstract][Full Text] [Related]
27. [Atopic dermatitis in children and adults].
Lipozencić J; Ljubojević S; Gregurić S
Acta Med Croatica; 2011; 65(2):87-96. PubMed ID: 22359873
[TBL] [Abstract][Full Text] [Related]
28. Protein Palmitoylation by ZDHHC13 Protects Skin against Microbial-Driven Dermatitis.
Chen LY; Yang-Yen HF; Tsai CC; Thio CL; Chuang HL; Yang LT; Shen LF; Song IW; Liu KM; Huang YT; Liu FT; Chang YJ; Chen YT; Yen JJY
J Invest Dermatol; 2017 Apr; 137(4):894-904. PubMed ID: 28017833
[TBL] [Abstract][Full Text] [Related]
29. Serum IgE in atopic dermatitis: relationship to severity of cutaneous involvement and course of disease as well as coexistence of atopic respiratory diseases.
Wüthrich B
Clin Allergy; 1978 May; 8(3):241-8. PubMed ID: 668097
[TBL] [Abstract][Full Text] [Related]
30. The potential role of allergen-specific sublingual immunotherapy in atopic dermatitis.
Mastrandrea F
Am J Clin Dermatol; 2004; 5(5):281-94. PubMed ID: 15554729
[TBL] [Abstract][Full Text] [Related]
31. The role of human beta defensins and cathelicidins in atopic dermatitis.
Howell MD
Curr Opin Allergy Clin Immunol; 2007 Oct; 7(5):413-7. PubMed ID: 17873581
[TBL] [Abstract][Full Text] [Related]
32. Infectious Complications in Atopic Dermatitis.
Sun D; Ong PY
Immunol Allergy Clin North Am; 2017 Feb; 37(1):75-93. PubMed ID: 27886912
[TBL] [Abstract][Full Text] [Related]
33. [The role of the innate immune system in atopic dermatitis].
Volz T; Kaesler S; Skabytska Y; Biedermann T
Hautarzt; 2015 Feb; 66(2):90-5. PubMed ID: 25633721
[TBL] [Abstract][Full Text] [Related]
34. Atopic dermatitis: insights from linkage overlap and disease co-morbidity.
Willis-Owen SA; Morar N; Willis-Owen CA
Expert Rev Mol Med; 2007 Apr; 9(9):1-13. PubMed ID: 17407613
[TBL] [Abstract][Full Text] [Related]
35. How the innate immune system trains immunity: lessons from studying atopic dermatitis and cutaneous bacteria.
Skabytska Y; Kaesler S; Volz T; Biedermann T
J Dtsch Dermatol Ges; 2016 Feb; 14(2):153-6. PubMed ID: 26788792
[TBL] [Abstract][Full Text] [Related]
36. The Pathogenetic Effect of Natural and Bacterial Toxins on Atopic Dermatitis.
Park KD; Pak SC; Park KK
Toxins (Basel); 2016 Dec; 9(1):. PubMed ID: 28025545
[TBL] [Abstract][Full Text] [Related]
37. Increasing Comorbidities Suggest that Atopic Dermatitis Is a Systemic Disorder.
Brunner PM; Silverberg JI; Guttman-Yassky E; Paller AS; Kabashima K; Amagai M; Luger TA; Deleuran M; Werfel T; Eyerich K; Stingl G;
J Invest Dermatol; 2017 Jan; 137(1):18-25. PubMed ID: 27771048
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-146a alleviates chronic skin inflammation in atopic dermatitis through suppression of innate immune responses in keratinocytes.
Rebane A; Runnel T; Aab A; Maslovskaja J; Rückert B; Zimmermann M; Plaas M; Kärner J; Treis A; Pihlap M; Haljasorg U; Hermann H; Nagy N; Kemeny L; Erm T; Kingo K; Li M; Boldin MP; Akdis CA
J Allergy Clin Immunol; 2014 Oct; 134(4):836-847.e11. PubMed ID: 24996260
[TBL] [Abstract][Full Text] [Related]
39. Effects of TS-022, a newly developed prostanoid DP1 receptor agonist, on experimental pruritus, cutaneous barrier disruptions and atopic dermatitis in mice.
Arai I; Takaoka A; Hashimoto Y; Honma Y; Koizumi C; Futaki N; Sugimoto M; Takahashi N; Inoue T; Nakanishi Y; Sakurai T; Tanami T; Yagi M; Ono N; Nakaike S
Eur J Pharmacol; 2007 Feb; 556(1-3):207-14. PubMed ID: 17141215
[TBL] [Abstract][Full Text] [Related]
40. The role of innate immune signaling in the pathogenesis of atopic dermatitis and consequences for treatments.
Skabytska Y; Kaesler S; Volz T; Biedermann T
Semin Immunopathol; 2016 Jan; 38(1):29-43. PubMed ID: 26573298
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
